$SDGR
Schrodinger, Inc.

2021 Q4 Form 10-K Financial Statement

#000156459022006713 Filed on February 24, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $46.17M $137.9M $33.03M
YoY Change 39.78% 27.6% 27.87%
Cost Of Revenue $19.81M $72.31M $14.04M
YoY Change 41.09% 62.05% 36.18%
Gross Profit $26.36M $65.62M $18.99M
YoY Change 38.82% 3.38% 22.28%
Gross Profit Margin 57.1% 47.57% 57.49%
Selling, General & Admin $23.73M $86.16M $18.26M
YoY Change 29.96% 44.34% 55.14%
% of Gross Profit 90.02% 131.3% 96.16%
Research & Development $25.15M $90.90M $17.32M
YoY Change 45.18% 40.51% 58.46%
% of Gross Profit 95.39% 138.53% 91.21%
Depreciation & Amortization $652.0K $2.847M $1.010M
YoY Change -35.45% -22.17% 10.99%
% of Gross Profit 2.47% 4.34% 5.32%
Operating Expenses $48.88M $177.1M $35.58M
YoY Change 37.37% 42.35% 52.25%
Operating Profit -$22.52M -$111.4M -$16.59M
YoY Change 35.71% 82.95% 111.61%
Interest Expense -$7.926M $10.64M $5.220M
YoY Change -251.84% -69.26% 679.1%
% of Operating Profit
Other Income/Expense, Net $10.64M
YoY Change -69.28%
Pretax Income -$30.44M -$100.8M -$11.36M
YoY Change 167.97% 283.42% 58.44%
Income Tax $274.0K $411.0K $230.0K
% Of Pretax Income
Net Earnings -$30.71M -$100.4M -$11.14M
YoY Change 175.7% 310.39% 64.55%
Net Earnings / Revenue -66.52% -72.78% -33.73%
Basic Earnings Per Share -$1.42
Diluted Earnings Per Share -$433.0K -$1.422M -$159.9K
COMMON SHARES
Basic Shares Outstanding 70.59M shares
Diluted Shares Outstanding 70.59M shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $576.5M $576.5M $642.7M
YoY Change -10.3% -10.3% 649.07%
Cash & Equivalents $120.3M $120.3M $202.3M
Short-Term Investments $456.2M $456.2M $440.4M
Other Short-Term Assets $8.030M $8.030M $4.900M
YoY Change 63.88% 63.88% -30.0%
Inventory
Prepaid Expenses $5.030M $4.409M
Receivables $31.74M $40.02M $31.42M
Other Receivables $536.0K $536.0K $4.000M
Total Short-Term Assets $625.1M $625.1M $683.0M
YoY Change -8.48% -8.48% 476.18%
LONG-TERM ASSETS
Property, Plant & Equipment $10.03M $85.41M $5.140M
YoY Change 95.04% 458.23% -18.0%
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments $43.17M $43.17M $45.66M
YoY Change -5.47% -5.54% 197.18%
Other Assets $2.851M $2.851M $2.352M
YoY Change 21.22% 18.79% 0.6%
Total Long-Term Assets $131.4M $131.4M $63.29M
YoY Change 107.67% 107.63% 72.28%
TOTAL ASSETS
Total Short-Term Assets $625.1M $625.1M $683.0M
Total Long-Term Assets $131.4M $131.4M $63.29M
Total Assets $756.5M $756.5M $746.3M
YoY Change 1.37% 1.37% 380.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.079M $8.079M $8.398M
YoY Change -3.8% -3.82% 138.31%
Accrued Expenses $27.76M $27.76M $19.40M
YoY Change 43.11% 43.11% 18.29%
Deferred Revenue $55.37M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $91.21M $91.21M $73.21M
YoY Change 24.6% 24.61% 62.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $300.0K $108.2M $654.0K
YoY Change -54.13% 120.8% -27.33%
Total Long-Term Liabilities $300.0K $108.2M $654.0K
YoY Change -54.13% 120.8% -27.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $91.21M $91.21M $73.21M
Total Long-Term Liabilities $300.0K $108.2M $654.0K
Total Liabilities $199.4M $199.4M $122.2M
YoY Change 63.12% 63.19% 114.41%
SHAREHOLDERS EQUITY
Retained Earnings -$230.0M -$129.6M
YoY Change 77.49% 23.28%
Common Stock $787.0M $753.2M
YoY Change 4.49% 6328.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $557.1M $557.1M $624.0M
YoY Change
Total Liabilities & Shareholders Equity $756.5M $756.5M $746.3M
YoY Change 1.37% 1.37% 380.62%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$30.71M -$100.4M -$11.14M
YoY Change 175.7% 310.39% 64.55%
Depreciation, Depletion And Amortization $652.0K $2.847M $1.010M
YoY Change -35.45% -22.17% 10.99%
Cash From Operating Activities -$19.74M -$70.67M $43.62M
YoY Change -145.25% -521.73% -487.05%
INVESTING ACTIVITIES
Capital Expenditures -$957.0K $7.167M -$890.0K
YoY Change 7.53% 182.39% 456.25%
Acquisitions $0.00
YoY Change
Other Investing Activities -$21.13M -$9.645M -$52.35M
YoY Change -59.63% -97.46% -901.68%
Cash From Investing Activities -$22.09M -$16.81M -$53.24M
YoY Change -58.51% -95.6% -935.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.217M 7.952M 1.420M
YoY Change -14.3% -98.53% -182.56%
NET CHANGE
Cash From Operating Activities -19.74M -70.67M 43.62M
Cash From Investing Activities -22.09M -16.81M -53.24M
Cash From Financing Activities 1.217M 7.952M 1.420M
Net Change In Cash -40.61M -79.53M -8.200M
YoY Change 395.27% -145.11% 23.87%
FREE CASH FLOW
Cash From Operating Activities -$19.74M -$70.67M $43.62M
Capital Expenditures -$957.0K $7.167M -$890.0K
Free Cash Flow -$18.78M -$77.84M $44.51M
YoY Change -142.2% -647.41% -500.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2021 dei Trading Symbol
TradingSymbol
SDGR
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
CY2020 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y7M28D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y5M26D
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
3519898945000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
73205000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y18D
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
30064000
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
41164000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M1D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1540 Broadway
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
24th Floor
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
CY2021 dei City Area Code
CityAreaCode
212
CY2021 dei Local Phone Number
LocalPhoneNumber
295-5800
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Auditor Firm
AuditorFirmId
185
CY2021 dei Auditor Name
AuditorName
KPMG LLP
CY2021 dei Auditor Location
AuditorLocation
Portland, OR
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120267000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202296000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3000000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
500000
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
456212000
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
440395000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
108000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31744000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31423000
CY2021Q4 sdgr Allowance For Unbilled Receivables Current
AllowanceForUnbilledReceivablesCurrent
30000
CY2020Q4 sdgr Allowance For Unbilled Receivables Current
AllowanceForUnbilledReceivablesCurrent
0
CY2021Q4 sdgr Unbilled And Other Receivables Current
UnbilledAndOtherReceivablesCurrent
8807000
CY2020Q4 sdgr Unbilled And Other Receivables Current
UnbilledAndOtherReceivablesCurrent
3955000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5030000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4409000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
625060000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
682978000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10025000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5140000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
43167000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
45664000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
75384000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10129000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2851000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2352000
CY2021Q4 us-gaap Assets
Assets
756487000
CY2020Q4 us-gaap Assets
Assets
746263000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8079000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8398000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
18405000
CY2020Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
12000000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
55368000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
45403000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2042000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4543000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7317000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2861000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91211000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77827000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7221000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
300000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
654000
CY2021Q4 us-gaap Liabilities
Liabilities
199402000
CY2020Q4 us-gaap Liabilities
Liabilities
122244000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61834515
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61834515
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60713534
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60713534
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
786964000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-229952000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-651000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
557071000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
14000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
557085000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
756487000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108095000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85543000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
90904000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22150000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17795000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64009000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41898000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27040000
CY2021 us-gaap Operating Expenses
OperatingExpenses
177063000
CY2020 us-gaap Operating Expenses
OperatingExpenses
124388000
CY2019 us-gaap Operating Expenses
OperatingExpenses
87808000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-111443000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-60916000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-38715000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1781000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4108000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
943000
CY2021 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
11359000
CY2020 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
28263000
CY2019 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
9922000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
1057000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
2253000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
1878000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10635000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
34624000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12743000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-100808000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26292000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25972000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
411000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
345000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-291000
CY2021 us-gaap Profit Loss
ProfitLoss
-101219000
CY2020 us-gaap Profit Loss
ProfitLoss
-26637000
CY2019 us-gaap Profit Loss
ProfitLoss
-25681000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-826000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2174000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1110000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100393000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-24463000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-24571000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.42
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.09
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
70594950
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60024658
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6004500
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100393000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-24463000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
301000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
25000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-101361000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24162000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24546000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-71560000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
25000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
549000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2193000
CY2019 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1151000
CY2019 us-gaap Profit Loss
ProfitLoss
-25681000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-93323000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4183000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10545000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
149824000
CY2020 sdgr Exchange Of Convertible Preferred Stock Into Limited Common Stock Value
ExchangeOfConvertiblePreferredStockIntoLimitedCommonStockValue
41756000
CY2020 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2137000
CY2020 us-gaap Profit Loss
ProfitLoss
-26637000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-968000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7927000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26490000
CY2021 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
836000
CY2021 us-gaap Profit Loss
ProfitLoss
-101219000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
557085000
CY2020 us-gaap Profit Loss
ProfitLoss
-26637000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1781000
CY2020 sdgr Noncash Revenue From Equity Investments
NoncashRevenueFromEquityInvestments
397000
CY2019 sdgr Noncash Revenue From Equity Investments
NoncashRevenueFromEquityInvestments
186000
CY2021 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
11359000
CY2020 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
28263000
CY2019 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
9922000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2847000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3658000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3640000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
26490000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
10545000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2193000
CY2021 sdgr Research And Development Noncash Expense
ResearchAndDevelopmentNoncashExpense
811000
CY2020 sdgr Research And Development Noncash Expense
ResearchAndDevelopmentNoncashExpense
2137000
CY2019 sdgr Research And Development Noncash Expense
ResearchAndDevelopmentNoncashExpense
1051000
CY2021 sdgr Investment Accretion Noncash Expense
InvestmentAccretionNoncashExpense
-5270000
CY2020 sdgr Investment Accretion Noncash Expense
InvestmentAccretionNoncashExpense
-646000
CY2019 sdgr Investment Accretion Noncash Expense
InvestmentAccretionNoncashExpense
506000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-140000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
321000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12747000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5038000
CY2021 sdgr Increase Decrease In Unbilled And Other Receivables
IncreaseDecreaseInUnbilledAndOtherReceivables
5187000
CY2020 sdgr Increase Decrease In Unbilled And Other Receivables
IncreaseDecreaseInUnbilledAndOtherReceivables
-3468000
CY2019 sdgr Increase Decrease In Unbilled And Other Receivables
IncreaseDecreaseInUnbilledAndOtherReceivables
1556000
CY2021 sdgr Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets
IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssets
-5799000
CY2020 sdgr Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets
IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssets
-5342000
CY2019 sdgr Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets
IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssets
-4177000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1121000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-187000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-410000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-411000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4882000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-294000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6405000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4966000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2948000
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1028000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
59705000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6715000
CY2021 sdgr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2949000
CY2020 sdgr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-5417000
CY2019 sdgr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-4025000
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3490000
CY2020 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1210000
CY2019 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
958000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70669000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16757000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26059000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7167000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2538000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1836000
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3700000
CY2020 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2869000
CY2021 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
375000
CY2020 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
4582000
CY2019 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
943000
CY2021 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
15735000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
414802000
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
519668000
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
110187000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
392747000
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
138772000
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
57225000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16812000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-381721000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53855000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
211491000
CY2020 sdgr Proceeds From Issuance Upon Follow On Public Offering Net
ProceedsFromIssuanceUponFollowOnPublicOfferingNet
325600000
CY2019 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
29893000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7927000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4183000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
549000
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
25000
CY2019 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
100000
CY2019 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1858000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7952000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
541274000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-79529000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202796000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26486000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
448000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
381000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
139000
CY2019 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
2142000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
705000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
90000
CY2021 sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsInExchangeForLeaseObligations
71054000
CY2020 sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsInExchangeForLeaseObligations
2709000
CY2019 sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsInExchangeForLeaseObligations
464000
CY2019 sdgr Noncash Or Part Noncash Right Of Use Assets Recognized On Adoption
NoncashOrPartNoncashRightOfUseAssetsRecognizedOnAdoption
16475000
CY2020 sdgr Noncash Or Part Noncash Reclassification Of Deferred Financing Costs To Additional Paid In Capital
NoncashOrPartNoncashReclassificationOfDeferredFinancingCostsToAdditionalPaidInCapital
1858000
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
90477000
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
185614000
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">j</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">)</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="font-weight:normal;font-style:normal;"/>Concentrations</p></td></tr></table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade receivables.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company does not require customers to provide collateral to support accounts receivable. If deemed necessary, credit reviews of significant new customers may be performed prior to extending credit. The determination of a customer’s ability to pay requires judgment, and failure to collect from a customer can adversely affect revenue, cash flows, and results of operations. </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, three customers accounted for 17%, 15%, and 11% of total accounts receivable, respectively. As of December 31, 2020, two customers accounted for 17% and 14% of total accounts receivable, respectively. For the year ended December 31, 2021, one customer accounted for 14% of total revenues. For the year ended December 31, 2020, no customer accounted for more than 10% of total revenues. For the year ended December 31, 2019, one customer accounted for 12% of total revenues.</p>
CY2021 us-gaap Royalty Expense
RoyaltyExpense
9826000
CY2020 us-gaap Royalty Expense
RoyaltyExpense
7663000
CY2019 us-gaap Royalty Expense
RoyaltyExpense
7352000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5140000
CY2021 sdgr Commission Expense
CommissionExpense
1829000
CY2020 sdgr Commission Expense
CommissionExpense
1362000
CY2019 sdgr Commission Expense
CommissionExpense
754000
CY2021 us-gaap Depreciation
Depreciation
2847000
CY2020 us-gaap Depreciation
Depreciation
3658000
CY2021Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.65
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
26694000
CY2021 sdgr Increase In Operating Lease Right Of Use Asset
IncreaseInOperatingLeaseRightOfUseAsset
71054000
CY2021 sdgr Increase In Operating Lease Liabilities
IncreaseInOperatingLeaseLiabilities
71054000
CY2021 us-gaap Lease Cost
LeaseCost
0
CY2021 sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
24695000
CY2020 sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
15565000
CY2019 sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
18808000
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8271000
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3589000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
42127000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
24921000
CY2021 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-113000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1887000
CY2021Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22380000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18942000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12355000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13802000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10025000
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021 sdgr Operating Lease Expiration Year
OperatingLeaseExpirationYear
2037
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y
CY2021 sdgr Number Of New Operating Leases
NumberOfNewOperatingLeases
2
CY2019 us-gaap Depreciation
Depreciation
3625000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
497660000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
485965000
CY2020 sdgr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Cash Contributions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCashContributions
2869000
CY2020 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-2977000
CY2021 sdgr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Cash Contributions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCashContributions
2000000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
7627000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
5895000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
5181000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
4561000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
6050000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
5108000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2087000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8809000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9632000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9241000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
8758000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
93656000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
132183000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
52314000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
79869000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2042000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77827000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
583000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
67000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
178000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-95000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
344000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
167000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-779000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
411000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
345000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-291000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
411000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
345000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-291000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-101341000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-24567000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-25385000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1359000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
449000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
523000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-99982000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24118000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
10632000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
394000
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
500000
CY2021Q4 sdgr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
18773000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24862000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.049
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.142
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.042
CY2019 sdgr Effective Income Tax Rate Reconciliation Withholding Taxes
EffectiveIncomeTaxRateReconciliationWithholdingTaxes
-0.023
CY2021 sdgr Effective Income Tax Rate Reconciliation Section162 Limitation
EffectiveIncomeTaxRateReconciliationSection162Limitation
-0.052
CY2020 sdgr Effective Income Tax Rate Reconciliation Section162 Limitation
EffectiveIncomeTaxRateReconciliationSection162Limitation
-0.128
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.124
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.685
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.002
CY2021 sdgr Effective Income Tax Rate Reconciliation Return To Provision Adjustments
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments
-0.017
CY2020 sdgr Effective Income Tax Rate Reconciliation Return To Provision Adjustments
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments
-0.013
CY2019 sdgr Effective Income Tax Rate Reconciliation Return To Provision Adjustments
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments
0.032
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.063
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.062
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.052
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.007
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.006
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.372
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.950
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.313
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.016
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.006
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.004
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.014
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.009
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
37149000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
67985000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
51498000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26119000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
10309000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
7918000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
6164000
CY2020Q4 sdgr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
2165000
CY2019Q4 sdgr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
433000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
14559000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
8752000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
7468000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
122258000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
70727000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40684000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95304000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
58155000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
35251000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
26954000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
12572000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5433000
CY2021Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
8545000
CY2020Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
10185000
CY2021 sdgr Maximum Percentage Of Stock Options Must Be Granted At Exercise Price Of Fair Market Value
MaximumPercentageOfStockOptionsMustBeGrantedAtExercisePriceOfFairMarketValue
1
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
1984000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
969000
CY2020Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
889000
CY2019Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
441000
CY2021Q4 sdgr Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
17440000
CY2020Q4 sdgr Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
1498000
CY2019Q4 sdgr Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
3008000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
283314000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
148130000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1046000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
902000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
781000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
282000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
25000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
24000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
20000
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
16000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
12000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
394000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
135000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
109000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1702000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1046000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
902000
CY2021 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
As of December 31, 2021, the Company’s statutes of limitations are open for all federal and state years tax returns filed after the years ended December 31, 2016 and 2015, respectively. Net operating loss and credit carryforwards for all years are subject to examination and adjustments for the three years following the year in which the carryforwards are utilized. The Company is not currently under Internal Revenue Service or state examination.
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1120981
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1398177
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
214845
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7927000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4183000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
549000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2283037
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.59
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.60
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.57
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0071
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0146
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0233
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26490000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10545000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2193000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7257460
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.14
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1696327
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
93.13
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1120981
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.00
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
149346
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
41.47
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3119
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.70
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7680341
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.19
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35584000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3473716
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.83
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
83306000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
45.07
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.55
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.93
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
71308000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
87946000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
546000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
78355000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y10M13D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
19080000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3153000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1734000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100393000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-24463000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-24571000
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
70594950
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60024658
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6004500
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.42
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.09
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7680341
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7257460
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
47540446
CY2020 us-gaap Gross Profit
GrossProfit
63472000
CY2021 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
401(k) employee savings plan to its U.S.‑based employees
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
1
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.040
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2592000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1748000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1492000
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
137931000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108095000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85543000
CY2021 us-gaap Gross Profit
GrossProfit
65620000
CY2019 us-gaap Gross Profit
GrossProfit
49093000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
90904000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64695000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39404000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22150000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17795000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21364000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64009000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41898000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27040000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1781000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4108000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
943000
CY2021 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
11359000
CY2020 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
28263000
CY2019 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
9922000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
1057000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
2253000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
1878000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
411000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
345000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-291000
CY2021 us-gaap Profit Loss
ProfitLoss
-101219000
CY2020 us-gaap Profit Loss
ProfitLoss
-26637000
CY2019 us-gaap Profit Loss
ProfitLoss
-25681000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
137931000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108095000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85543000

Files In Submission

Name View Source Status
0001564590-22-006713-index-headers.html Edgar Link pending
0001564590-22-006713-index.html Edgar Link pending
0001564590-22-006713.txt Edgar Link pending
0001564590-22-006713-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g0na1tfcz5u2000001.jpg Edgar Link pending
g0na1tfcz5u2000002.jpg Edgar Link pending
g0na1tfcz5u2000003.jpg Edgar Link pending
g0na1tfcz5u2000004.jpg Edgar Link pending
g0na1tfcz5u2000005.jpg Edgar Link pending
g0na1tfcz5u2000006.jpg Edgar Link pending
g0na1tfcz5u2000007.jpg Edgar Link pending
g0na1tfcz5u2000008.jpg Edgar Link pending
g0na1tfcz5u2000009.jpg Edgar Link pending
g0na1tfcz5u2000010.jpg Edgar Link pending
g0na1tfcz5u2000011.jpg Edgar Link pending
g0na1tfcz5u2000012.jpg Edgar Link pending
g0na1tfcz5u2000013.jpg Edgar Link pending
g0na1tfcz5u2000014.jpg Edgar Link pending
g0na1tfcz5u2000015.jpg Edgar Link pending
g0na1tfcz5u2000016.jpg Edgar Link pending
g0na1tfcz5u2000017.jpg Edgar Link pending
g0na1tfcz5u2000018.jpg Edgar Link pending
g0na1tfcz5u2000019.jpg Edgar Link pending
g0na1tfcz5u2000020.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdgr-10k_20211231.htm Edgar Link pending
sdgr-10k_20211231_htm.xml Edgar Link completed
sdgr-20211231.xsd Edgar Link pending
sdgr-20211231_cal.xml Edgar Link unprocessable
sdgr-20211231_def.xml Edgar Link unprocessable
sdgr-20211231_lab.xml Edgar Link unprocessable
sdgr-20211231_pre.xml Edgar Link unprocessable
sdgr-ex105_247.htm Edgar Link pending
sdgr-ex106_246.htm Edgar Link pending
sdgr-ex211_9.htm Edgar Link pending
sdgr-ex231_7.htm Edgar Link pending
sdgr-ex311_12.htm Edgar Link pending
sdgr-ex312_11.htm Edgar Link pending
sdgr-ex321_8.htm Edgar Link pending
sdgr-ex322_10.htm Edgar Link pending
Show.js Edgar Link pending